We found DYRK1A inhibition was also able to suppress the shortened life associated with pan-neuronal overexpression of AD-associated Tau or Aβ42, again this was only a partial rescue with the treated flies living longer than their equivalent untreated genotype control but not as long as completely normal flies. This evidence concerns the gene DYRK1A and Alzheimer disease.